Healthcare -
Biotechnology - NASDAQ - US
$ 1.8349
-1.75 %
$ 17 M
Market Cap
-0.5
P/E
SABS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SABS - SAB Biotherapeutics, Inc.
-1.17 M
LAST VALUE
-1.70%
2 YEAR CAGR
-5.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR